GlassScriptPhysician profile
Amanda Thuy Vu
NPI 1184308652
$2,067.78
in general payments reported to CMS, 2019-2025
10 companies · $1,710 in 2025
The $1,710 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $126 · 2024: $232 · 2025: $1,710.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,068.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,067.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,582.73 | 2023-2025 | Hoffmann, Augment Injectable, Inbone |
| Axogen | $126.25 | 2025 | |
| Treace Medical Concepts, INC. | $81.88 | 2024-2025 | |
| Fusion Orthopedics USA, LLC | $64.34 | 2025 | |
| Paratek Pharmaceuticals, INC. | $54.50 | 2025 | Nuzyra |
| Trilliant Surgical LLC. | $44.83 | 2025 | Minimally Invasive Bunion Plate, Left |
| Globus Medical, INC. | $37.89 | 2025 | Anthem |
| Mimedx Group, INC. | $30.84 | 2024 | |
| Coloplast Corp | $26.50 | 2024 | |
| Smith+Nephew, INC. | $18.02 | 2024 | Collagenase Santyl, Regranex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Vu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.